All posts by imreal

Clearwater Again Rated a Top Performer in KLAS Research Review of Security & Privacy Consulting Services Market


Our most important value at Clearwater is our commitment to customer success. This independent KLAS report reflects the high levels of expertise, quality, and partnership we strive to bring to each engagement.

Clearwater is proud to announce that it is once again rated a top performer in a new KLAS Research report reviewing the Security and Privacy Consulting Services market. KLAS is a data-driven company aiming to improve the world’s healthcare by enabling provider and payer voices to be heard and counted. Working with thousands of healthcare professionals, KLAS collects insights on software, services and medical equipment to deliver reports, trending data and statistical overviews.

The new report titled “Security and Privacy Consulting Services 2022: Who Exceeds Expectations in This High-Performing Market?” reviews the firms that specialize in enhancing security and data privacy measures in healthcare. KLAS examines several such firms to determine who effectively assists in reducing risk, engages closely with clients, and exceeds expectations.

Among the companies rated in the category with 15 or more unique customer data points, Clearwater’s performance rating leads the way. The rating is based on customer feedback that KLAS researchers have obtained over the last 18 months.

One of the Chief Information Security Officers that KLAS interviewed recently made the following statement about Clearwater:

“The firm’s specialty is healthcare. So they are highly adaptive, highly agile, and up-to-date on newer technologies. I don’t see any weaknesses there. The firm’s consulting services are absolutely fantastic. We have had discussions at the leadership level. The team gets things done, stays in contact, and meets deliverables. I honestly couldn’t be happier. Clearwater is what we would want any firm to be.”

KLAS researchers also gathered this comment from a Chief Information Officer recently:

“Clearwater is very healthcare focused, and I have gotten good feedback from my personal network that they are smart people that do their job well. We can always tell when a company is stretched a little thin and is just sticking a body in when they don’t have an answer. Clearwater seems to have a very strong bench with smart people. They always have the right answer for us and can always get the right people on the phone.”

While the report focuses specifically on consulting services, it mentions that Clearwater also provides software and managed services that are used by healthcare organizations to address security and privacy concerns.

“Strong cybersecurity partners have never been more needed in healthcare, and we are very gratified to be recognized as one in this new KLAS report,” says Clearwater CEO Steve Cagle. “Our most important value at Clearwater is our commitment to customer success. This independent KLAS report reflects the high levels of expertise, quality, and partnership we strive to bring to each engagement. The experience and expertise of our consulting team combined with the innovative, data-driven capabilities of our software platform IRM|Pro® and the 24×7 Managed Detection and Response capabilities we’ve gained through our acquisition of TECH LOCK, provides our customers with a powerful ally in securing their organizations from a rapidly evolving threat landscape.”

About Clearwater

Clearwater is the leading provider of risk-based cybersecurity and compliance software, consulting, and managed services for the healthcare industry. Our solutions enable organizations to avoid preventable breaches, protect patients and their data, meet regulatory requirements, and optimize cybersecurity investments. More than 400 healthcare organizations, including 70 of the nation’s largest health systems and a large universe of physician groups and digital health companies, trust Clearwater to meet their cybersecurity and compliance needs. For more information about Clearwater, please visit http://www.clearwatercompliance.com.

Note: The CIO and CISO quotes included in this press release were captured by KLAS Research in May 2022 and March 2022, respectively, and are being used with KLAS’ permission.

Share article on social media or email:

Three Marietta OB-GYN Affiliates, P.A Physicians Recognized as 2022 Top Doctors in Atlanta Magazine


News Image

“We are so honored to have three of our exceptional physicians recognized in Atlanta Magazine’s 2022 Top Doctors list,” says a Marietta OB/GYN Affiliates, P.A representative.

The trusted physicians at Marietta OB-GYN Affiliates, P. A are among an esteemed group being recognized by colleagues and peers in the Atlanta metro area as the best doctors specializing in obstetrics and gynecology. Atlanta Magazine partners with Castle Connolly Medical Ltd., a healthcare research firm based in New York, to complete the Top Doctor survey. A randomly selected sample of board-certified physicians and key medical leaders identified exceptional doctors in their respective specialties. As a result of the hundreds of medical professionals surveyed, Atlanta’s Top Doctors are named, and doctors do not and cannot pay to be selected and profiled. The respected physicians and nurse practitioners at Marietta OB/GYN Affiliates, P. A provides a broad range of women’s care from young adolescence to pregnancy, menopause and beyond. Services offered at Marietta OB/GYN Affiliates, P. A includes specialized treatments relating to pregnancy, the reproductive system and complex gynecologic surgeries. These well-respected doctors are passionate about providing patients with the excellent medical care they deserve. Dr. Khan-Simba has over 12 years of experience in the medical field. She graduated from the University of Illinois – Chicago / School of Public Health in 2010 and completed her residency training in obstetrics and gynecology at Saint Joseph Hospital in Chicago. Dr. Elizabeth Taghechian earned her medical degree at the Medical College of Georgia in 1998 and completed her residency training in obstetrics and gynecology at Greenville Memorial Hospital, in Greenville, S.C. in 2002. Dr. Carlos Alarcon graduated from Emory University School Of Medicine in 2006 and also finished his residency training at Emory in Atlanta, GA.

“We are so honored to have three of our exceptional physicians recognized in Atlanta Magazine’s 2022 Top Doctors list,” says a Marietta OB/GYN Affiliates, P.A representative.

About Marietta OB/GYN Affiliates, P.A.:

Marietta OB/GYN Affiliates, P.A has two locations, the Kennestone Outpatient Pavilion clinic at 699 Church Street, Suite 220 in Marietta, GA and the West Cobb clinic at 5041 Dallas Hwy, Suite 115 in Powder Springs, GA. The physicians and nurse practitioners at this practice provide a broad range of women’s medical care and specialized care in the area of the reproductive system, meeting the medical needs of women, ranging from adolescence through menopause and beyond. For more information about Marietta OB-GYN Affiliates, P.A. or to schedule an appointment, please visit their website at http://www.mariettaobgyn.com or call the office at (770) 422-8505.

Share article on social media or email:

Developing Clinically Relevant Models for Evaluating Novel Therapies, Upcoming Webinar Hosted by Xtalks


The speaker will also discuss the importance of selecting clinically relevant glioblastoma models that closely recapitulate human glioblastoma as well as specialized intracranial engraftment and dosing techniques.

The blood-brain barrier (BBB) is a critical obstacle to developing brain-penetrant therapies for glioblastoma research and treatment. Orthotopic intracranial glioblastoma models (orthotopic means “the correct place”) are a next-generation platform that provide accurate preclinical data to inform lead candidate progression into the clinic.

During this free webinar, the featured speaker will reveal innovations in glioblastoma model development and the future of glioblastoma research, diving into critical issues affecting glioblastoma drug development and how to overcome them. Attendees will review an in-depth case study illustrating in vivo and in vitro approaches to model glioblastoma via 3D spheroid and intracranial orthotopic patient-derived xenograft (O-PDX) models. The speaker will also discuss the importance of selecting clinically relevant glioblastoma models that closely recapitulate human glioblastoma as well as specialized intracranial engraftment and dosing techniques.

Reserve your place in this webinar to learn about the future of glioblastoma research and how to overcome challenges with glioblastoma drug development.

Join Monika Buczek, PhD, Director, Business Development, Certis Oncology Solutions, for the live webinar on Wednesday, September 14, 2022, at 2pm EDT (11am PDT).

For more information, or to register for this event, visit The Future of Glioblastoma Research: Developing Clinically Relevant Models for Evaluating Novel Therapies.

ABOUT CERTIS

Certis Oncology Solutions is a life science technology company committed to realizing the promise of precision oncology. Our product is “Oncology Intelligence™—highly predictive therapeutic response data derived from advanced biological models of cancer. Our proprietary platform informs individual treatment decisions and accelerates the development of new cancer therapies. Certis partners with therapeutics developers to help close the problematic “translation gap” between preclinical studies and clinical trials. Through more clinically relevant, well-characterized and annotated models, advanced imaging technology and thoughtfully designed studies, Certis brings greater certainty to go/no-go development decisions.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

CDHF Partners with NutriProCan IBS Program Designed to Relieve or Resolve IBS Symptoms


According to Gastroenterology Journal, IBS affects an estimated 18% of the population worldwide, and more women suffer from IBS than men. In a survey by the Gastrointestinal Society in 2018, IBS patients reported that they would give up 15 years of their life to live symptom-free.

Common approaches to managing IBS symptoms involve attempts to follow a low FODMAP diet, taking pre/probiotic (as well as other) supplements, medications as well as exercise and mental health supports. The trials and errors of an IBS journey can cause depression, and the sudden and embarrassing symptoms alone are known to cause anxiety and stress day in and day out.

For those struggling with the often disruptive symptoms of Irritable Bowel Syndrome (IBS), NutriProCan Dietitians offer a comprehensive IBS Program that is aimed at resolving symptoms while focusing on the quality of life and avoiding excessive restriction. The process of receiving a definitive diagnosis can take up to 4 years. However, a diagnosis is not required to start managing symptoms with a dietitian-led program.

“I suffered from severe IBS for over 20 years. Unable to go to the club with friends, dates with my wife, or even complete tasks at my work, all because of the constant need to find bathrooms on very short notice. I had been to countless Dr, naturopaths, and intestinal specialists and even tried hypnotherapy. Unfortunately, nothing had worked. I couldn’t believe I had never tried a dietitian, but I am absolutely amazed by the results. I started my journey in February 2021, and by the end of March 2021, I was a new person. I couldn’t believe the relief I had been given. It feels like I have a new chance at life. I am able to go out to dinners, play more sports, and have dates with my wife. I have been able to travel comfortably for work and try things I have never thought possible. I even took the most memorable motorcycle trip with my father, something I thought I would never be able to do. I am so grateful for the work Nav has done for me. Setting up personalized meal plans and closely monitoring my progress through the low FODMAP elimination and re-introduction phases. As if the freedom to be able to venture out without even the thought of bathrooms wasn’t enough, through the entire process, I was able to drop 50lbs. I feel like an entirely new person and could not recommend Nutriprocan more. If you are suffering from any intestinal discomfort or issues like IBS, please check them out. Truly game-changing,” wrote Kevin Holtby, a NutriProCan client.

“It is my pleasure to be offering another resource for those affected by IBS. Nutrition is at the heart of IBS treatment, and we understand that an IBS Diet must be personalized, evidence-based as well as considered for nutrient-drug interactions, which registered dietitians are qualified to review and advise on,” said Kelsey Cheyne, ED of Canadian Digestive Health Foundation.

As part of this strategic collaboration, NutriProCan will donate a portion of the IBS package proceeds to CDHF and offer additional support for digestive health education and resources through CDHF.

“I am thrilled about the trifecta of this collaboration where we are adding a highly beneficial tool, the MyIBS App, into our IBS Program, increasing awareness about treatment options, as well as supporting the important work CDHF does,” said Lisa Spriet, President & CEO of NutriProCan.

About CDHF

Canadian Digestive Health Foundation (CDHF) is Canada’s trusted resource on digestive health. Committed to providing useful, up-to-date information and research to help Canadians better manage digestive conditions and live healthier lives.

About NutriProCan

NutriProCan has been supporting Canadians since 2015 with a team of Registered Dietitians dedicated to providing science-based nutrition advice and education. NutriProCan Dietitians offer clients virtual counselling and programs for various health concerns in Ontario, Alberta and British Columbia.

Share article on social media or email:

Mount Sinai Awarded $11.6 Million Grant to Launch Comprehensive Center for Surgical Innovation and Expand Mount Sinai BioDesign


In a move that has the potential to change the future of surgery, advance quality care, and bring economic growth to New York City, Mount Sinai Health System announced today the launch of the Comprehensive Center for Surgical Innovation (CCSI). This bold new initiative is supported by an $11.6 million grant from Mayor Eric Adams and New York City Economic Development Corporation (NYCEDC) and expands upon the activities of Mount Sinai Biodesign, the Health System’s device incubator.

Mayor Adams made the announcement on Wednesday that Mount Sinai Health System along with The City College of New York (CCNY) would each receive multimillion-dollar investments to support the construction of new facilities.

“With these awards, our administration is making critical investments in the health and prosperity of New Yorkers,” said Mayor Adams. “Life sciences are central to our city’s public health and economic recovery, and we will continue to marshal the resources necessary to grow this industry, create new economic opportunities for New Yorkers, and keep our city moving forward.”

The Center will be located in a new state-of-the-art facility at 432 West 58th Street in Midtown Manhattan, steps from the Mount Sinai West hospital campus. The CCSI will facilitate and accelerate the development and commercialization of innovative technologies and instrumentation that will enhance the safety, quality, and efficiency of surgical procedures, resulting in improved outcomes among patients in New York City and globally. It will propel innovation in surgical technology development by training a diverse generation of researchers, engineers, and physicians, resulting in solutions that reflect a wider range of perspectives, cultures, and backgrounds and thus have wide-reaching benefits.

This investment from NYCEDC is intended to amplify the efforts of Mount Sinai BioDesign, which has attracted innovative startup companies and venture capital to New York City and has inspired new ventures generating commercial licensing agreements and millions in funding. The new CCSI will build upon success in scaling innovative discoveries, nurturing collaborative partnerships with industry leaders, and supporting a pipeline of young entrepreneurs who launch startup companies that bring new ideas to the market and into surgical arenas around the world. These initiatives will not only improve the delivery of care but also generate new jobs, diversify the pool of life sciences talent, and serve as a major driver of economic development for New York City.

“We are thrilled to award this funding to Mount Sinai Health System to launch the Comprehensive Center for Surgical Innovation, said NYCEDC President and CEO Andrew Kimball. “Strategic investments like this by NYCEDC’s LifeSci NYC initiative bridge research, innovative technologies, commercialization, and education to support biomedical leaders to advance groundbreaking research and health care technologies in New York City. We look forward to the startups, jobs, and life changing medical devices this Center will yield to support patient care and treatment.”

“Mount Sinai BioDesign’s mission is to help patients by creating technological solutions for their medical problems, to generate jobs and high-value assets in New York City, and to educate a diversified generation of engineers, scientists, and clinicians,” said Joshua Bederson, MD, Leonard I. Malis, MD/Corinne and Joseph Graber Professor and Chair of Neurosurgery at the Mount Sinai Health System. “Thanks to this key investment in the new Comprehensive Center for Surgical Innovation by the Mayor and NYCEDC, we envision a crosscutting incubator lab where our talented scientists, programs, prototyping, and testing will bring new devices to market that promise to change the future of medicine and surgery.”

“Mount Sinai has been in a leader in the innovation space with the primary goals of solving complex health issues for patients and advancing science and medicine,” said Evan L. Flatow, MD, Bernard J. Lasker Professor of Orthopedics, President of Mount Sinai West, and Director of the Comprehensive Center for Surgical Innovation. “Throughout my career, I’ve been involved in surgical innovation and leading efforts to develop next-generation joint replacements. It has been a lifelong dream of mine to build a surgical innovation lab at Mount Sinai to bring surgical discoveries and innovative methods into commercial health solutions that benefit patients. This dream is now a reality thanks to the support of the Mayor and the NYCEDC, and our collaboration with Mount Sinai BioDesign. The investment in the Comprehensive Center for Surgical Innovation will enable rapid development of new breakthroughs and products, along with new commercial enterprises that result in sustainable job creation and economic growth.”

The Center also builds on Mount Sinai’s commitment to accelerate the pace of life sciences and bioengineering innovation and entrepreneurship in New York City. That commitment is reflected in the spring 2022 announcement of the Center for Engineering and Precision Medicine—a partnership between Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai that will create one of the first centers nationwide to bridge engineering and engineering science with medicine.

“Mount Sinai has tremendous momentum in innovation, actualizing many achievements and successes in patient-centric solutions, and bringing these to the market and to the patients who need them,” said Erik Lium, PhD, Chief Commercial Innovation Officer at the Mount Sinai Health System, and President of Mount Sinai Innovation Partners. “The new surgical innovation center, alongside existing and future academic and industry partners, will harness research, clinical, and commercial strengths to rapidly advance breakthrough devices to the clinic.”

“The Mount Sinai Health System and the Icahn School of Medicine are dynamic ecosystems for innovators. We have created an environment that fosters innovation and attracts best-in-class researchers and collaborators from across the nation and globe,” said Dennis S. Charney, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and President for Academic Affairs of Mount Sinai Health System. “We are driven by a larger mission to work together, leveraging unique points of views and experiences, to solve the most intricate challenges in medicine and life sciences. To be bold and relentless in our pursuits and to find a way to advance medicine for the benefit of every human being.”

In addition to the oversight provided by Drs. Flatow, Bederson, and Lium, leadership will be provided by Benjamin I. Rapoport, MD, PhD, Assistant Professor of Neurosurgery and Scientific Director of Mount Sinai BioDesign, and by Scott L. Friedman, MD, Irene and Dr. Arthur M. Fishberg Professor of Medicine, Dean for Therapeutic Discovery, and Chief of Liver Diseases at Icahn Mount Sinai.

About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report’s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools,” aligned with a U.S. News & World Report “Honor Roll” Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally. For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter, and YouTube.

Author Daisy Thomas’ new book “At Least Ten Years of Trick or Treat” is a powerful tale of the author’s fight to protect herself and her children from her husband


News Image

Daisy Thomas, an assistant pastor and Bible Institute coordinator at Prosperity Center of World Churches in Jackson, Mississippi, has completed her new book “At Least Ten Years of Trick or Treat”: a potent autobiographical account that details the author’s struggles as she tried her best to shield her children from her abusive husband.

“Many of us grow up in a world of make-believe, a world where only good comes to good people and bad people are punished for the wrong they do,” writes Thomas. “We hear the stories of our martyrs, Martin Luther King Jr., Harriet Tubman, and John Fitzgerald Kennedy, and realize they were good people. They did good deeds, but good as we know it did not always come back to them, for they were killed by assassins. We believe when we do the right thing, we will reap righteousness. We read the stories of Jesus Christ and His suffering, death, and resurrection on earth, then we read that we are to arm (prepare for the type of suffering He experienced) ourselves likewise; however, we do not believe that we will be hated by all men for the name of Christ. Jesus was rejected by men and sentenced in court by a judge who knew He was not guilty. He was released into the hands of political leaders who were afraid of losing their income. Many of His relatives and friends chose a guilty man instead. Some of His close friends and associates stood outside and even chose to curse and swear so they would not be associated with Him. Today, many of us do not believe our relatives and friends will hurt us.

“Having always believed whatever seeds men and women sow they will live to reap, or what goes around comes around, it did not occur to me we can sow seeds unintentionally or through vain thoughts of the imagination and live to reap them as well.”

Published by Page Publishing, Daisy Thomas’ compelling tale will show the ugliness that can take hold in one’s heart who claims to serve God, and what often occurs behind closed doors. Relying on her inner strength and God’s guidance, Thomas shows how she managed to rise above the evil that was destroying her family and did what she had to do to protect her children.

Readers who wish to experience this gripping work can purchase “At Least Ten Years of Trick or Treat” at bookstores everywhere, or online at the Apple iTunes Store, Amazon, Google Play, or Barnes and Noble.

For additional information or media inquiries, contact Page Publishing at 866-315-2708.

About Page Publishing:

Page Publishing is a traditional, full-service publishing house that handles all the intricacies involved in publishing its authors’ books, including distribution in the world’s largest retail outlets and royalty generation. Page Publishing knows that authors need to be free to create, not mired in logistics like eBook conversion, establishing wholesale accounts, insurance, shipping, taxes, and so on. Page’s accomplished writers and publishing professionals allow authors to leave behind these complex and time-consuming issues and focus on their passion: writing and creating. Learn more at http://www.pagepublishing.com.

Share article on social media or email:

The Lord’s Prayer” is an informative discussion of a beloved prayer.


News Image

“The Christian Approach: The Lord’s Prayer”: a thoughtful and encouraging approach to deepening one’s understanding of the Lord’s Prayer. “The Christian Approach: The Lord’s Prayer” is the creation of published authors Corey Fabricatore and Pastor Roland Preisler.

Fabricatore and Pastor Preisler share, “Prayer is one of the most important aspects of the Christian life. Prayer is so important that Jesus made it a point to show his followers how to pray using the Lord’s Prayer when he taught the Sermon on the Mount. It is paramount for Christians to understand the Lord’s Prayer and how to pray to God using the method that Jesus taught us. The Christian Approach: The Lord’s Prayer brings that understanding in a clear and concise way. In The Christian Approach: The Lord’s Prayer, Pastor Roland Preisler, and Corey Fabricatore provide a comprehensive biblical examination of what prayer is, crucial information regarding the prayer, what the individual elements of the Lord’s Prayer are, and what’s the meaning behind each element of the Lord’s Prayer. By the end of this book, you are sure to have a better understanding and appreciation for that infamous prayer that our Lord and Savior Jesus Christ taught!”

Published by Christian Faith Publishing, Corey Fabricatore, and Pastor Roland Preisler’s new book will bring readers a helpful resource for reflection and encouragement in their prayer life.

Fabricatore and Pastor Preisler share a compelling discussion of the intricacies of prayer that will empower readers in their spiritual journey.

Consumers can purchase “The Christian Approach: The Lord’s Prayer” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “The Christian Approach: The Lord’s Prayer,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Organizing Data and Document Archives Webinar on September 8, 2022


Organizing Data and Document Archives

Finding a Needle in a Haystack for FDA Inspections

An FDAnews Webinar

Thursday, Sept. 8, 2022, 1:30 p.m. – 3:00 p.m. EDT

https://wcg.swoogo.com/organizing-data-and-document-archives-sept-2022

Pharmaceutical, medical device, biologics and diagnostics companies need to easily put their hands on the documents FDA investigators request.

In order to do this they need to create effective new SOPs for electronic document management or improve existing ones.

FDAnews has invited David L. Chesney, MSJ, a leading GXP (GCP/GLP/GMP) consultant to help manufacturers gain control of their data. In 90-minutes, attendees will learn the basics of developing best practices and SOPs that effectively turn inspections into routine management tasks. They will learn:


  • How to determine which data are most likely to be requested during an inspection
  • How to develop assessments to gauge the risk of not being able to find a document
  • The top 10 questions to ask about the archival process
  • What to do when documents are not in the general archives
  • When emails count as GXP documentation
  • How to explain missing documents to investigators
  • If the source data is electronic, how to provide access to the regulatory authority
  • If the source data is paper that was scanned, what to do with the originals

Webinar Details

Organizing Data and Document Archives

Finding a Needle in a Haystack for FDA Inspections

An FDAnews Webinar

Thursday, Sept. 8, 2022, 1:30 p.m. – 3:00 p.m. EDT

https://wcg.swoogo.com/organizing-data-and-document-archives-sept-2022

Price:

$287

Easy Ways to Order:

Online: https://wcg.swoogo.com/organizing-data-and-document-archives-sept-2022

By phone: 888.838.5578 or 703.538.7600

About WCG FDAnews:

WCG FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on WCG FDAnews’ newsletters, books, databases, webinars and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations. Learn more at fdanews.com.

Share article on social media or email:

Clarion Safety Systems Offers Resources for Understanding ANSI Z535 and ISO 3864 Standards Compliance


Clarion Safety’s featured guidebook is available free for download.

Our new ANSI and ISO resources are a reflection of the clear and concise guidance that Clarion Safety is committed to providing to serve the product safety and compliance community.

Clarion Safety Systems, a leading manufacturer of safety labels, signs, and tags, has released a complimentary guidebook accompanied by further resources on its website, detailing the intricacies of ANSI Z535.4 and ISO 3864-2 labeling compliance for North American and international manufacturers. This new and comprehensive guide on label format options – as well as brief and clear cut infosheets on the ANSI and ISO standards that the company has developed – contain information to help manufacturers comply with the latest best practices for labels and recent updates from each standards organization.

“Manufacturers have a number of core responsibilities related to the machinery or equipment they produce. That includes designing safe products that comply with relevant regional best practices, such as those for product labels and warnings. For decades, manufacturers have turned to the ANSI and ISO standards to guide their efforts. However, the standards are not prescriptive – and there are many nuances related to how to practically apply them, especially as the standards themselves and the safety landscape evolve over time. This is where the Clarion Safety team can come in to help,” says Ron Crawford, CEO of Clarion Safety.

“Our new ANSI and ISO resources are a reflection of the clear and concise guidance that Clarion Safety is committed to providing to serve the product safety and compliance community. When it comes to best practice standards like ANSI Z535.4 and ISO 3864-2, our Clarion Safety team is ready to assist, helping companies to take out any guesswork, lost time, or anxiety involved in meeting labeling requirements, and harmonizing the two standards together.”

Latest Updates to the ANSI and ISO Standards

There are two main standards for safety labels that are key to creating effective warnings: ANSI Z535.4 domestically in the U.S. and ISO 3864-2 internationally.

“By striving to follow industry consensus standards that define today’s best practices in visual safety communication, equipment manufacturers can improve product safety and reduce their liability exposure,” says Angela Lambert, head of standards compliance at Clarion Safety. Lambert also represents Clarion Safety as the chair of ANSI Z535.1, as a delegate representative of the U.S. TAG to the ISO/TC 145, responsible for the library of ISO 7010 registered symbols and the ISO 3864 set of standards, and as a liaison between ISO TC/283 and ISO/TC 145 committees.

Both the ANSI and ISO standards are reviewed and revised periodically. ANSI Z535 is being republished in 2022. This year marks the first time many of the standards in the ANSI Z535 family – including ANSI Z535.4 – have been reviewed and updated in more than 10 years. Three of the six ANSI standards (Z535.1, Z535.3, and Z535.5) were republished in August, and the remaining three (Z535.2, Z535.4, and Z535.6) are expected to be published before the end of the year. ISO 3864-2 was republished in 2022 without any changes, however, the previous republication in 2016 contained significant updates related to format options and symbol use.

Clarion Safety’s Guidebook Detailing Key Topics for ANSI and ISO Standards Compliance

Through its recently released guidebook, Clarion Safety details the following key topics as they relate to manufacturers:

Section 1: A Historical Overview of ANSI Z535.4 and ISO 3864-2

Section 2: The Comparison of Different Labeling Options for Manufacturers

Section 3: Symbol Only Formats Label Compliance and Use

Section 4: Symbol and Text Formats Label Compliance and Use

Section 5: Text Only Formats Label Compliance and Use

Section 6: Wordless Formats Label Compliance and Use

Section 7: Multilingual Formats Label Compliance and Use

These sections cover an in-depth analysis of the different ways to apply the ANSI and ISO warning and labeling standards to suit a manufacturers’ specific product and environment.

Infosheets and Additional Resources to Aid Manufacturers in How to Follow Today’s Best Practices

Clarion Safety’s free downloadable ANSI Z535.4 and ISO 3864-2 guide was developed to go hand-in hand with its new online safety resources – which includes downloadable infosheets with details on each standard – that help manufacturers better understand ANSI and ISO as a whole.

Along with these new educational resources, Clarion Safety also offers free label review services which include evaluating a current or future products’ labeling system and providing recommendations on consolidation opportunities as well as how to harmonize the ANSI and ISO standards for the application at hand. An additional service offered by Clarion Safety’s team of experts is their comprehensive machinery and equipment risk assessments. These assessments are intended for manufacturers in all stages of product design and development, including the initial stages of the design cycle, the final development of the product, and after placement on the market.

To learn more about risk assessment and compliance, visit Clarion Safety’s machinery safety and risk assessment services.

Clarion Safety also accepts media inquiries and speaking opportunities related to workplace safety and risk and visual communications best practices. To submit a media inquiry, visit the company’s “Newsroom” and select the “For the Media” tab.

ABOUT CLARION SAFETY SYSTEMS

Clarion Safety Systems, LLC, is the leading designer and manufacturer of visual safety solutions that help customers in more than 180 industries worldwide to make their products and premises safer. Clarion Safety offers a full range of standard and custom products including machinery safety labels, environmental and facility safety signs, pipe and valve identification markings, lockout/tagout products, and safety-grade photoluminescent egress path-marking escape systems. The company also provides complementary services for comprehensive machine safety, compliance and risk reduction. Founded in 1990, Clarion Safety continues to play a leading role in the development and writing of international and national standards for safety signs, labels, and markings. It is headquartered at 190 Old Milford Road in Milford, PA, 18337, and online at http://www.clarionsafety.com.

Share article on social media or email:

Angel Groups Collaborate to Support Medical Device Portfolio Company’s $300 Million Exit


“We are delighted to have supported Standard Bariatrics along their journey and believe the commercial potential for their important surgical offerings are enhanced by this transaction,” said Queen City Angels founder and chair Tony Shipley.

The Board of Standard Bariatrics announced that it has entered in a definitive agreement with Teleflex Incorporated, a leading global provider of medical technologies, under which Teleflex will acquire Standard Bariatrics, a Queen City Angels portfolio company, upon the satisfaction of customary closing conditions, for an upfront cash payment of $170 million at closing, with additional consideration of up to $130 million payable upon the achievement of certain commercial milestones.

“We couldn’t be prouder of Founder Dr. Jonathan Thompson and CEO Matt Sokany for all of their work to get Standard Bariatrics to this milestone,” said Queen City Angels founder and chair Tony Shipley. “We are delighted to have supported Standard Bariatrics along their journey and believe the commercial potential for their important surgical offerings are enhanced by this transaction,” added Shipley.

Queen City Angels was an initial investor in Standard Bariatrics in 2016. “Standard Bariatrics represents one of the largest investments in a single portfolio company in our 22-year history,” said John Habbert, co-manager of QCA First Funds. “We’ve invested in six follow-on rounds to help fuel the company’s progress. This underscores our confidence in the incredible work of Mr. Sokany and Dr. Thompson, and their entire team.”

In addition to Queen City Angels, other angel groups who invested are North Coast Ventures, Ariel Savannah Angel Partners, Life Science Angels, and Accelerant Fund. Other investors include JobsOhio, CincyTech, RC Capital, US Venture Partners, Hatteras Venture Partners, Rivervest and Emergent Medical Partners.

Standard Bariatrics is another successful exit for a QCA portfolio company. “Since we started QCA more than 20 years ago, we have invested over $85 million in more than 100 companies, said Shipley. “Our investments have been leveraged with over $700 million of additional capital invested by others in our portfolio companies. Some of our earlier investments include Assurex Health (where we led the initial investment in the company), T-Pro Solutions, ConnXus, among a group of other successful companies.”

“While we have a very strong current portfolio, we continue our work to identify additional investment opportunities,” said Scott Jacobs, QCA Executive Director. “We continue to see strong ‘deal flow,’ both in the Cincinnati region and beyond.”

Additional information on the Standard Bariatrics transaction can be found here: https://investors.teleflex.com/news/news-details/2022/Teleflex-to-Expand-Its-Surgical-Portfolio-with-Differentiated-Stapling-Technology-for-Bariatric-Surgery/default.aspx

Share article on social media or email: